Number of Shares
2.83 Mil
Current Holdings Value*
$57.83 Mil
% of Portfolio
4.35%
Total Estimate Gain
$6.11 Mil
% of Total Estimate Gain
9.25%

Cormorant Asset Management, LP's NewAmsterdam Pharma Co NV Holding Summary

As of 2025-03-31, Cormorant Asset Management, LP held 2.83 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $57.83 Mil. This investment constitutes 4.35% of their stock portfolio, and Cormorant Asset Management, LP now holds 2.52% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.

The initial trade took place in 2024Q1. And since then Cormorant Asset Management, LP has made 4 purchases of NAMS, at an average price of $20.32, for a total of 3.25 Mil shares. In addition, there have been 1 sales at an average price of $22.23 for 425,000.00 shares. Based on historical transaction data and NAMS's current price of $22.20, Cormorant Asset Management, LP's estimated gain on his NAMS holdings is $6.11 Mil, reflecting a 9.25% gain to date.

Cormorant Asset Management, LP NAMS ($22.20) Holding Chart

Cormorant Asset Management, LP NAMS ($22.20) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1